Development of a Point-of-Care Assay for HIV-1 Viral Load Using Higher Refractive Index Antibody-Coated Microbeads.

Development of a Point-of-Care Assay for HIV-1 Viral Load Using Higher Refractive Index Antibody-Coated Microbeads.
复制标题

DOI:
10.3390/s21051819
复制
发表时间:
2021-03-05
期刊:
Sensors (Basel, Switzerland)
影响因子:
--
通讯作者:
Asghar W
Asghar W
中科院分区:
其他
文献类型:
--
作者:
Sher M;Coleman B;Caputi M;Asghar W

文献摘要

参考文献

被引文献

相似文献

利用成像技术检测病毒具有挑战性,因为纳米尺寸的目标所产生的光散射很弱。我们开发的系统通过利用折射率较高且涂有抗体的微珠克服了光散射问题,这些微珠能够与病毒特异性结合并增大接收角。利用这项新技术,我们开发了一种便携式、成本效益高且可在现场部署的平台,用于在即时检验(POC)环境中快速定量检测HIV - 1病毒载量。该系统将微流体技术与宽视场无透镜成像技术相结合。高特异性抗体被功能化到微芯片内的载玻片上以捕获HIV - 1病毒粒子。然后,被捕获的病毒粒子与具有较高折射率且结合了抗体的微珠结合。微珠 - HIV - 1病毒粒子复合物产生衍射图案,这些图案由定制的成像装置检测,并通过计算分析快速准确地定量。这种平台技术能够对生物样本中的纳米级病毒进行快速成像和定量,因此在病毒性疾病的检测和管理中可发挥重要作用。
The detection of viruses using imaging techniques is challenging because of the weak scattering of light generated by the targets of sizes in the nanometer range. The system we have developed overcomes the light scattering problems by utilizing antibody-coated microbeads of higher index of refraction that can specifically bind with viruses and increase the acceptance angle. Using the new technology, we have developed a portable, cost-effective, and field-deployable platform for the rapid quantification of HIV-1 viral load for point-of-care (POC) settings. The system combines microfluidics with a wide field of view lensless imaging technology. Highly specific antibodies are functionalized to a glass slide inside a microchip to capture HIV-1 virions. The captured virions are then bound by antibody-conjugated microbeads, which have a higher refraction index. The microbeads—HIV-1 virions complexes generate diffraction patterns that are detected with a custom-built imaging setup and rapidly and accurately quantified by computational analysis. This platform technology enables fast nanoscale virus imaging and quantification from biological samples and thus can play a significant role in the detection and management of viral diseases.
DOI: 10.1016/j.optlaseng.2020.106326
发表时间: 2021-02-01
影响因子: 4.6
作者:
Fennell, Robert D.;Sher, Mazhar;Asghar, Waseem
通讯作者: Asghar, Waseem
DOI: 10.1073/pnas.1015638108
发表时间: 2011-05-03
影响因子: 11.1
作者:
Isikman, Serhan O.;Bishara, Waheb;Ozcan, Aydogan
通讯作者: Ozcan, Aydogan
DOI: 10.1021/nl103210p
发表时间: 2010-11-01
期刊: NANO LETTERS
影响因子: 10.8
作者:
Daaboul, G. G.;Yurt, A.;Uenlue, M. S.
通讯作者: Uenlue, M. S.
急性HIV-1感染。
DOI: 10.1056/nejmra1011874
发表时间: 2011-05-19
期刊: The New England journal of medicine
影响因子: --
作者:
Cohen MS;Shaw GM;McMichael AJ;Haynes BF
通讯作者: Haynes BF
DOI: 10.1016/j.antiviral.2009.10.002
发表时间: 2010-01
期刊: Antiviral research
影响因子: 7.6
作者:
Broder S
通讯作者: Broder S